About Index Trending news
Analyze
Pricing
Genomind

Genomind

Genomind

Genomind is a personalized medicine company. The Genecept Assay is a saliva-based genetic test that helps inform clinician treatment decisions.
I work here Suggest edits
More info

Elsewhere

Contributors to this profile

Companies in the same industry

Creative Bioarray Creative Bioarray Provia Laboratories Provia Laboratories Fibrocell Science Fibrocell Science FE3 MEDICAL INC FE3 MEDICAL INC Quantapore Inc. Quantapore Inc. Prosensa Prosensa Adnexus Adnexus Morphogen-IX Morphogen-IX eXIthera Pharmaceuticals eXIthera Pharmaceuticals Comfort Line Comfort Line

Alexa global traffic share

Twitter followers

Terms of Service API Integrations Plans & Pricing
Built with ❤︎ by Datalicious ©2017
A daughter company of TNW.
Index.co is not affiliated with Index Ventures.

Overview

Funding 5
Add info
Add round
08 Feb 2017
$11,000,000
Venture capital
Silicon Valley Bank

Genomind(R) Completes $11 Million Financing to Fund Business Expansion

Marketwire
20 Apr 2016
$17,950,000
Venture capital
Claritas Capital

SEC FORM D/A

sec
+1
10 Feb 2016
$4,750,000
Venture capital

SEC FORM D/A

sec
22 Sep 2015
$6,000,000
Venture capital (Series B)
Claritas Capital

Genomind Secures Latest Round of Financing That Will Solidify Strategic Plan for Company's Growth

EIN Newsdesk
09 Apr 2014
$5,000,000
Venture capital (Series A)
Claritas Capital

Genomind Closes $5M Financing

FinSMEs